CIAM
IMRX icon

Caitong International Asset Management’s Immuneering IMRX Stock Holding History

Caitong International Asset Management’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,998
Closed -$32.9K – 2812
2025
Q4 		$32.9K Buy
+4,998
New +$32.1K 0.01% 859

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Caitong International Asset Management's IMRX Position: Q1 2026 in Review

Caitong International Asset Management sold out of Immuneering (IMRX) in Q1 2026, closing a stake of 4,998 shares — an estimated $32.9K sold.

Caitong International Asset Management first reported a position in IMRX in Q4 2025 and held it in 1 quarter. The position peaked at $32.9K in Q4 2025. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

  • Caitong International Asset Management reported no remaining Immuneering position as of Q1 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 4,998 Immuneering shares in Q1 2026, an estimated $32.9K.
  • Caitong International Asset Management first reported a position in Immuneering in Q4 2025 and held it in 1 quarter.
  • Caitong International Asset Management's Immuneering position peaked at $32.9K in Q4 2025.
  • 95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.